Career Enhancement Program

职业提升计划

基本信息

  • 批准号:
    10683959
  • 负责人:
  • 金额:
    $ 9.52万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-07-16 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

Career Enhancement Program: Project Summary/Abstract The goal of the Career Enhancement Program (CEP) is to use the translational research resources at the MD Anderson Cancer Center (MDACC) to solicit and award faculty-level investigators interested in intensive career development in the field of melanoma research to improve melanoma early detection, prevention, and treatment. Experienced mentors serve to assist CEP awardees to develop their careers as melanoma experts, with the goal to reduce the morbidity and mortality from this disease. The CEP will support up to three one-year awards of $50,000 annually, with a second-year renewal based on acceptable progress. Funds for the CEP include an annual $50,000 from the SPORE throughout the duration of the overall award, as well as up to $100,000 per year in institutional “matching funds” from MDACC. Candidates will include the most promising faculty-level investigators from our institution as well as from the entire Texas Medical Center, and other SPOREs, with which we interact. The selection of CEP awardees will be based on the scientific uniqueness, quality, and novelty of the research proposal and the appropriateness of the mentoring plan, which will be evaluated and scored by our Internal and External Advisory Boards (IAB; EAB). The awardees will meet with their designated mentors regularly and with CEP leadership at least monthly, and are expected to participate in and report their progress at monthly SPORE investigator meetings and annual IAB/EAB meetings. The CEP is led by Dr. Elizabeth Grimm for mentees with laboratory-based projects and Dr. Jeffrey E. Lee for mentees with clinical projects; both will be involved to mentor translational researchers.
职业提升计划:项目摘要/摘要 职业提升计划(CEP)的目标是利用 MD安德森癌症中心(MDACC)征集并奖励对强化治疗感兴趣的教职员工级别的研究人员 在黑色素瘤研究领域的职业发展,以提高黑色素瘤的早期发现,预防, 和治疗。经验丰富的导师帮助CEP获奖者发展他们的黑色素瘤职业生涯 专家说,目的是减少这种疾病的发病率和死亡率。CEP将最多支持 三个一年奖,每年50,000美元,根据可接受的进展情况,第二年续期。 CEP的资金包括整个奖项期间孢子每年提供的50,000美元, 以及MDACC每年高达100,000美元的机构“配对资金”。候选人将包括 来自我们机构以及整个德克萨斯医学会的最有前途的教职员工级别的研究人员 中心,和其他孢子,我们与之互动。CEP获奖者的遴选将基于 研究方案的科学独特性、质量和新颖性以及指导的适当性 该计划将由我们的内部和外部咨询委员会(IAB;EAB)进行评估和评分。这个 获奖者将定期与他们指定的导师会面,并至少每月与CEP领导层会面,以及 预计将参加每月孢子调查员会议和年度会议并报告进展情况 IAB/EAB会议。CEP由伊丽莎白·格林博士领导,为以实验室为基础的项目和 杰弗里·E·李博士为临床项目的导师;两人都将参与指导翻译研究人员。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jennifer A. Wargo其他文献

The bacterial microbiome modulates the initiation of brain metastasis by impacting the gut-to-brain axis
细菌微生物组通过影响肠道-大脑轴来调节脑转移的起始。
  • DOI:
    10.1016/j.isci.2025.111874
  • 发表时间:
    2025-02-21
  • 期刊:
  • 影响因子:
    4.100
  • 作者:
    Matteo Massara;Michelle Ballabio;Bastien Dolfi;Golnaz Morad;Vladimir Wischnewski;Eleni Lamprou;Joao Lourenco;Stéphanie Claudinot;Hector Gallart-Ayala;Rui Santalla Méndez;Annamaria Kauzlaric;Nadine Fournier;Ashish V. Damania;Matthew C. Wong;Julijana Ivanisevic;Nadim J. Ajami;Jennifer A. Wargo;Johanna A. Joyce
  • 通讯作者:
    Johanna A. Joyce
MAdCAM-1: a newly identified microbial 'gut check' for T cells
MAdCAM-1:一种新发现的针对 T 细胞的微生物“肠道检查”
  • DOI:
    10.1016/j.it.2023.06.007
  • 发表时间:
    2023-08-01
  • 期刊:
  • 影响因子:
    13.900
  • 作者:
    Manoj Chelvanambi;Jennifer A. Wargo
  • 通讯作者:
    Jennifer A. Wargo
Case 21-2013
案例21-2013
  • DOI:
  • 发表时间:
    2013
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Ryan J. Sullivan;Donald P. Lawrence;Jennifer A. Wargo;Kevin S. Oh;R. Gonzalez;A. Piris
  • 通讯作者:
    A. Piris
Gut microbes as biomarkers of ICI response — sharpening the focus
肠道微生物作为免疫检查点抑制剂反应的生物标志物——聚焦
  • DOI:
    10.1038/s41571-022-00634-0
  • 发表时间:
    2022-04-21
  • 期刊:
  • 影响因子:
    82.200
  • 作者:
    Neal Bhutiani;Jennifer A. Wargo
  • 通讯作者:
    Jennifer A. Wargo
Errant central line placement
  • DOI:
    10.1016/j.jclinane.2007.06.003
  • 发表时间:
    2007-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Robert A. Peterfreund;Jennifer A. Wargo
  • 通讯作者:
    Jennifer A. Wargo

Jennifer A. Wargo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jennifer A. Wargo', 18)}}的其他基金

Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)
项目2 鞘内注射抗PD-1免疫疗法治疗患有软脑膜疾病(LMD)的转移性黑色素瘤患者
  • 批准号:
    9978777
  • 财政年份:
    2020
  • 资助金额:
    $ 9.52万
  • 项目类别:
Project 2 Intrathecal Anti-PD-1 Immunotherapy for Metastatic Melanoma Patients with Leptomeningeal Disease (LMD)
项目2 鞘内注射抗PD-1免疫疗法治疗患有软脑膜疾病(LMD)的转移性黑色素瘤患者
  • 批准号:
    10208809
  • 财政年份:
    2020
  • 资助金额:
    $ 9.52万
  • 项目类别:
Career Enhancement Program
职业提升计划
  • 批准号:
    10415942
  • 财政年份:
    2019
  • 资助金额:
    $ 9.52万
  • 项目类别:
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
(PQ10) 通过调节微生物组增强黑色素瘤中免疫检查点阻断的反应
  • 批准号:
    9789214
  • 财政年份:
    2018
  • 资助金额:
    $ 9.52万
  • 项目类别:
(PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome
(PQ10) 通过调节微生物组增强黑色素瘤中免疫检查点阻断的反应
  • 批准号:
    10245169
  • 财政年份:
    2018
  • 资助金额:
    $ 9.52万
  • 项目类别:
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma
探索联合 BRAF 靶向治疗的协同作用
  • 批准号:
    8522168
  • 财政年份:
    2012
  • 资助金额:
    $ 9.52万
  • 项目类别:
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma
探索联合 BRAF 靶向治疗的协同作用
  • 批准号:
    9121489
  • 财政年份:
    2012
  • 资助金额:
    $ 9.52万
  • 项目类别:
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma
探索联合 BRAF 靶向治疗的协同作用
  • 批准号:
    8383369
  • 财政年份:
    2012
  • 资助金额:
    $ 9.52万
  • 项目类别:
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma
探索联合 BRAF 靶向治疗的协同作用
  • 批准号:
    8926888
  • 财政年份:
    2012
  • 资助金额:
    $ 9.52万
  • 项目类别:
Exploring synergy of combined BRAF-targeted therapy & immunotherapy for melanoma
探索联合 BRAF 靶向治疗的协同作用
  • 批准号:
    8706085
  • 财政年份:
    2012
  • 资助金额:
    $ 9.52万
  • 项目类别:

相似海外基金

Transfer Advocacy Groups: Transforming Culture to Support Community College Transfer Students of Color in Undergraduate Physics
转学倡导团体:转变文化以支持社区学院本科物理有色人种转学生
  • 批准号:
    2224295
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Continuing Grant
Engaging adolescents for sexual and reproductive health and rights and family planning advocacy in Pakistan.
让巴基斯坦青少年参与性健康和生殖健康及权利以及计划生育宣传。
  • 批准号:
    490127
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Operating Grants
Developing a network for mutual learning on the potential of creative arts for mental health advocacy and activism in Ghana and Indonesia
建立一个网络,以相互学习创意艺术在加纳和印度尼西亚促进心理健康倡导和行动的潜力
  • 批准号:
    AH/X009637/1
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Research Grant
Protection without Advocacy: Japan's Failure to Support Persons with Mental Disabilities in the community
没有倡导的保护:日本未能支持社区中的精神残疾人
  • 批准号:
    23K01937
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Developing a cultural adaptation framework for youth mental health education and advocacy initiatives at Jack.org
Jack.org 为青少年心理健康教育和宣传活动制定文化适应框架
  • 批准号:
    484618
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Fellowship Programs
8th International RASopathies Symposium: Expanding Research and Care Practice through Global Collaboration and Advocacy
第八届国际 RASopathies 研讨会:通过全球合作和宣传扩大研究和护理实践
  • 批准号:
    10683644
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
Lupus and health information: Evidence-informed advocacy in action
狼疮和健康信息:循证宣传在行动
  • 批准号:
    485670
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Miscellaneous Programs
Initiating Meaningful Partnerships for Advocacy and Collaborative Training: The IMPACT initiative
发起有意义的倡导和协作培训伙伴关系:IMPACT 倡议
  • 批准号:
    487847
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Miscellaneous Programs
Creating advocacy and tech to make secondhand first choice.
创造宣传和技术,让二手货成为首选。
  • 批准号:
    10064859
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Collaborative R&D
Advocacy Strategies supporting Social Determinants of Health: Paving the Path to Community Reintegration and Recovery
支持健康问题社会决定因素的倡导策略:为社区重新融入和恢复铺平道路
  • 批准号:
    480718
  • 财政年份:
    2023
  • 资助金额:
    $ 9.52万
  • 项目类别:
    Miscellaneous Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了